Stockreport

Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development [Yahoo! Finance]

Edgewise Therapeutics, Inc.  (EWTX) 
PDF Behrad Derakhshan, Ph.D., Chief Operating Officer, Edgewise Therapeutics (Photo: Business Wire) - Robert Blaustein, M.D., Ph.D. appointed as Chief Development Officer [Read more]